AVAH vs. ETON
AVAH (Aveanna Healthcare Holdings Inc.) and ETON (Eton Pharmaceuticals Inc) are both stocks. Both are in the Healthcare sector — AVAH in Medical Care Facilities, ETON in Drug Manufacturers - Specialty & Generic. Over the past 5 years, AVAH returned -11.13%/yr vs 34.31%/yr for ETON. At a 0.21 correlation, their price movements are largely independent.
Performance
AVAH vs. ETON - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVAH achieves a -20.81% return, which is significantly lower than ETON's 62.03% return.
AVAH
- 1D
- -3.00%
- 1M
- -2.12%
- YTD
- -20.81%
- 6M
- -28.98%
- 1Y
- 18.28%
- 3Y*
- 70.30%
- 5Y*
- -11.13%
- 10Y*
- —
ETON
- 1D
- -4.46%
- 1M
- -5.19%
- YTD
- 62.03%
- 6M
- 78.27%
- 1Y
- 45.44%
- 3Y*
- 91.85%
- 5Y*
- 34.31%
- 10Y*
- —
AVAH vs. ETON - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
AVAH Aveanna Healthcare Holdings Inc. | -20.81% | 78.77% | 70.52% | 243.59% | -89.46% | -38.33% |
ETON Eton Pharmaceuticals Inc | 62.03% | 26.95% | 204.11% | 55.32% | -34.27% | -49.71% |
Correlation
The correlation between AVAH and ETON is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 29, 2021 | 0.21 |
Fundamentals
AVAH:
$1.44B
ETON:
$864.39M
AVAH:
$1.20
ETON:
-$0.05
AVAH:
0.56
ETON:
8.84
AVAH:
5.99
ETON:
28.23
AVAH:
$2.52B
ETON:
$86.93M
AVAH:
$823.98M
ETON:
$47.61M
AVAH:
$306.37M
ETON:
$5.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVAH vs. ETON — Risk / Return Rank
AVAH
ETON
AVAH vs. ETON - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aveanna Healthcare Holdings Inc. (AVAH) and Eton Pharmaceuticals Inc (ETON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AVAH | ETON | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.27 | 0.82 | -0.55 |
Sortino ratioReturn per unit of downside risk | 1.11 | 1.52 | -0.41 |
Omega ratioGain probability vs. loss probability | 1.13 | 1.19 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 0.54 | 1.25 | -0.70 |
Martin ratioReturn relative to average drawdown | 0.98 | 2.27 | -1.29 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AVAH | ETON | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.27 | 0.82 | -0.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.14 | 0.54 | -0.69 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.15 | 0.34 | -0.49 |
Drawdowns
AVAH vs. ETON - Drawdown Comparison
The maximum AVAH drawdown since its inception was -94.76%, which is greater than ETON's maximum drawdown of -79.94%. Use the drawdown chart below to compare losses from any high point for AVAH and ETON.
Loading charts...
Drawdown Indicators
| AVAH | ETON | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.76% | -79.94% | -14.82% |
Max Drawdown (1Y)Largest decline over 1 year | -39.44% | -36.17% | -3.27% |
Max Drawdown (3Y)Largest decline over 3 years | -41.40% | -45.65% | +4.25% |
Max Drawdown (5Y)Largest decline over 5 years | -94.76% | -70.42% | -24.34% |
Current DrawdownCurrent decline from peak | -49.81% | -21.71% | -28.10% |
Average DrawdownAverage peak-to-trough decline | -63.72% | -37.69% | -26.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.72% | 19.83% | +1.89% |
Volatility
AVAH vs. ETON - Volatility Comparison
The current volatility for Aveanna Healthcare Holdings Inc. (AVAH) is 16.20%, while Eton Pharmaceuticals Inc (ETON) has a volatility of 17.90%. This indicates that AVAH experiences smaller price fluctuations and is considered to be less risky than ETON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVAH | ETON | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.20% | 17.90% | -1.70% |
Volatility (6M)Calculated over the trailing 6-month period | 31.74% | 41.06% | -9.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.09% | 55.75% | +12.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.17% | 63.46% | +14.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.64% | 63.96% | +13.68% |
Dividends
AVAH vs. ETON - Dividend Comparison
Neither AVAH nor ETON has paid dividends to shareholders.
Financials
AVAH vs. ETON - Financials Comparison
This section allows you to compare key financial metrics between Aveanna Healthcare Holdings Inc. and Eton Pharmaceuticals Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AVAH vs. ETON - Profitability Comparison
AVAH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aveanna Healthcare Holdings Inc. reported a gross profit of 202.38M and revenue of 647.92M. Therefore, the gross margin over that period was 31.2%.
ETON - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported a gross profit of 14.74M and revenue of 24.27M. Therefore, the gross margin over that period was 60.7%.
AVAH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aveanna Healthcare Holdings Inc. reported an operating income of 75.94M and revenue of 647.92M, resulting in an operating margin of 11.7%.
ETON - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported an operating income of 2.41M and revenue of 24.27M, resulting in an operating margin of 10.0%.
AVAH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aveanna Healthcare Holdings Inc. reported a net income of 41.65M and revenue of 647.92M, resulting in a net margin of 6.4%.
ETON - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported a net income of 1.55M and revenue of 24.27M, resulting in a net margin of 6.4%.
Frequently Asked Questions
AVAH and ETON have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ETON has higher volatility (17.90%) compared to AVAH (16.20%). In terms of maximum drawdown, AVAH dropped -94.76% vs ETON's -79.94%.
ETON currently has the higher Sharpe Ratio (0.82 vs 0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVAH and ETON
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer